If you are researching robotic prostate surgery, you may come across Versius, a robotic system developed by CMR Surgical. Unlike da Vinci, it uses several small robotic units that your surgeon positions around you and controls from a console with a 3D view.
Versius has been used for robotic prostate removal in the UK and internationally, but its evidence base is newer than da Vinci’s. For you, the robot is only one factor to consider alongside your surgeon’s experience, surgical approach and individual cancer.
What Exactly Is the Versius Surgical System?
If you are considering robotic prostate surgery, Versius is a surgeon-controlled system that helps your surgeon perform minimally invasive surgery. It does not operate by itself, so your surgeon remains in control of every important step.
Versius uses a 3D camera and separate robotic units with wristed instruments. These units can be positioned around you, giving your surgeon flexibility in how the instruments are arranged and controlled within your pelvis.
Who Developed Versius?
If you are researching Versius, you may want to know that CMR Surgical, a medical technology company based in Cambridge, UK, developed it. Versius received its European CE mark in 2019, so you are considering a newer robotic system than da Vinci.
For you, this means Versius is already being used in clinical surgery and has growing published evidence. However, you should remember that you will not find the same amount of long-term clinical follow-up as you would with older robotic systems.
Versius and da Vinci: Key Differences
| Feature | Versius | da Vinci |
| System design | Modular bedside units | Different integrated patient-cart architectures depending on model |
| Instrument positioning | Individual bedside units can be positioned separately | Robotic arms are arranged through the patient cart/system architecture |
| Surgeon console | Open console | Console design varies by da Vinci generation |
| Vision | 3D HD visualisation | 3D HD visualisation |
| Instruments | Fully wristed instruments | Wristed robotic instruments |
| Prostatectomy evidence | Growing, but relatively recent | Much longer-established evidence base |
| Does design prove better outcomes? | No | No |
How Is Versius Different From a Da Vinci Robot?

If you are comparing Versius with da Vinci, you will notice that Versius uses separate mobile units for the camera and surgical instruments. Your surgeon can position these units independently around you, rather than using one large patient-side structure.
You will also see a different surgeon console and wristed instruments designed for precise movements. While these design features may change how your surgery is performed, you should not assume they will give you better prostate cancer outcomes.
What Does “Modular” Robotic Surgery Mean?
If you are considering Versius, “modular” means that its camera and surgical instruments are held by separate mobile units rather than one large robotic structure. Your surgical team can position these units around you based on your operation, body shape and available theatre space.
For you, this may give your surgeon more options for positioning the instruments during prostate surgery. However, modularity mainly affects system configuration and surgical workflow; it does not automatically mean better cancer treatment.
How Does the Surgeon Control Versius?
Your surgeon controls Versius from a dedicated console while viewing the surgical area in magnified 3D.
- Dedicated console: Your surgeon operates the robotic system using hand controls at the console.
- Magnified 3D view: The system provides a detailed three-dimensional view of your anatomy during surgery.
- Precise instrument movement: Versius translates your surgeon’s hand movements into controlled movements at the instrument tips.
- Bedside team support: The surgical team remains beside you to assist throughout the procedure.
Your surgeon remains responsible for all clinical decisions and controls the robotic instruments throughout your operation.
Why Might Wristed Instruments Help During Prostatectomy?
If you are having a prostatectomy, your surgeon needs to work deep inside your pelvis where space is limited. Wristed robotic instruments can give your surgeon more freedom to work around your prostate and place precise stitches.
For you, this can be especially useful when your bladder is reconnected to your urethra after surgery. Wristed instruments are not unique to Versius, as da Vinci and other robotic systems also use them.
How Is Versius Used for Radical Prostatectomy?

If radical prostatectomy is suitable for your prostate cancer, your surgeon can use Versius to remove your prostate and usually the seminal vesicles. Depending on your cancer, your surgeon may also remove nearby lymph nodes and try to preserve the nerves that help with erections.
After your prostate is removed, your surgeon reconnects your bladder to your urethra and leaves a catheter while you heal. For you, Versius mainly changes how your surgeon controls and positions the instruments during the operation.
Clinical Tip
If Versius is being considered for your prostatectomy, ask how many procedures your surgeon and theatre team have performed using the system. Moving from one robotic platform to another involves differences in setup, controls, instruments and workflow.
You can also ask how the team monitors outcomes such as complications, surgical margins, urinary continence and erectile-function recovery. The platform is only one part of the operation; experience with both prostatectomy and the specific robotic system remains important.
When Was Versius First Used for Prostate Removal in the UK?
If you are looking at Versius for prostate surgery, you may want to know that the first UK prostate removal using the system took place at Guy’s Hospital in December 2021. This marked the first UK prostate removal using Versius within the NHS.
Since then, you can find more clinical experience and research on Versius prostate surgery. However, because Versius is newer than da Vinci, you will find less long-term evidence about your results.
UK Guidance Note
NICE included Versius in its 2025 assessment of several robot-assisted surgical platforms. However, prostatectomy was excluded from that assessment because robot-assisted prostatectomy is already established NHS practice.
This means NICE’s assessment should not be interpreted as recommending Versius over da Vinci for prostate cancer surgery. The choice of platform should be considered alongside the surgeon’s experience, the planned operation and the evidence for the specific technique.
What Did the Early Versius Prostatectomy Studies Find?
If you are looking at Versius for prostate surgery, early studies mainly examined the feasibility, safety and consistency of performing prostatectomy with the system. Researchers also studied how the separate robotic units could be positioned around you to give your surgeon good access and avoid arm clashes.
For you, this research shows that surgeons are still refining how they use Versius during prostatectomy. More research is needed to understand how it may affect your long-term cancer control, urinary function and sexual recovery.
Evidence Note
The prospective COMPAR-P study compared 50 Versius prostatectomies with 50 da Vinci procedures performed by experienced robotic surgeons. Blood loss and complication rates were similar, but Versius had longer setup and console times in this early experience, and technical malfunctions were reported more frequently. Performance improved as experience with Versius increased.
A later six-month COMPAR-P analysis comparing da Vinci, Hugo RAS and Versius found no significant differences in most safety, PSA-related or patient-reported outcomes between the three groups. However, each group contained only 50 patients and follow-up was short, so these findings do not establish long-term equivalence.
What Does the Meta-Analysis Tell Us About Versius Prostatectomy?
If you are researching Versius prostate surgery, a 2025 review combined four studies involving 145 patients. The review looked at important results for you, including operating time, blood loss, complications, surgical margins and continence recovery.
For you, this gives some early information about what to expect after Versius prostatectomy, but it cannot predict your individual recovery. The studies were small and varied, so you should consider larger and longer-term research when comparing Versius with other robotic systems.
Research Insight
A 2025 meta-analysis combined four Versius prostatectomy studies involving 145 patients. The pooled positive surgical-margin rate was 32%, while continence recovery was reported in 43% of patients at one month, 65% at two months and 73% at three months. Major complications above Clavien–Dindo grade II were reported in around 7%.
These figures should be interpreted cautiously. The review was based on a small number of single-arm studies with considerable differences between them, so it cannot establish that Versius provides better or equivalent outcomes to another robotic system. Larger prospective comparative studies are still needed.
What Do Longer-Term Versius Results Show?

If you are considering Versius for prostate surgery, you can now find studies looking beyond early recovery. A 2026 study followed 60 men for a median of 29.5 months, giving you more information about PSA levels, surgical margins and cancer findings after surgery.
For you, these results provide useful early follow-up, but they cannot predict your long-term outcome. The study was small and the follow-up was still relatively short, so you should look for more research on Versius over the coming years.
What Does the Positive Surgical-Margin Rate Mean?
If you are reading about prostate surgery, a positive surgical margin means cancer cells were found at the edge of your removed prostate. This can increase your risk of PSA recurrence, but it does not mean that your cancer will definitely return.
For you, the margin rate depends on factors such as your cancer stage, grade and your surgeon’s technique, not just the robotic system used. You should therefore avoid comparing Versius and da Vinci by margin percentages alone, as the patients and their cancers may be very different.
What Do We Know About Continence After Versius Surgery?
If you are considering radical prostatectomy, you may wonder when you will regain urinary control. Early Versius studies report improving continence rates during the first few months after surgery, but your age, urinary function, anatomy and surgical technique can all affect your recovery.
For you, the robotic system is only one part of your recovery. Your surgeon’s experience and how carefully your sphincter and surrounding structures are preserved can also affect how quickly you regain control.
Does Versius Improve Erectile-Function Recovery?
If you are concerned about erections after prostate surgery, there is not enough evidence to show that Versius gives you better recovery than other robotic systems. Your age, erections before surgery and cancer location can all affect your recovery.
Versius gives your surgeon 3D vision and wristed instruments that can support nerve-sparing surgery when appropriate. However, this cannot guarantee erectile recovery, so you should discuss your cancer, nerve-sparing options and your surgeon’s results.
What Are the Potential Advantages and Limitations of Versius?
If you are considering Versius, you may find its separate robotic units and open console give your surgical team more flexibility around you. Your surgeon can also use its 3D vision and wristed instruments, which are designed to support controlled movements in confined areas.
However, you should remember that Versius is newer than da Vinci, so there is less long-term evidence from prostate surgery. Your surgeon and theatre team may also need time to develop experience with the system.
How Should You Decide Whether Versius Is Appropriate for Your Prostate Surgery?

If you are considering Versius, you should first understand whether robotic prostatectomy is suitable for your prostate cancer. Your Grade Group, PSA, stage, MRI findings, health and treatment priorities can all influence this decision.
For you, your surgeon’s experience with Versius and the planned surgical approach are also important. If you are exploring robotic prostate surgery in London, ask about your surgeon’s experience, nerve-sparing, lymph-node surgery and expected recovery.
Myth vs Fact
| Myth | Fact |
| Versius performs the prostatectomy automatically. | The surgeon controls the robotic instruments and makes the surgical decisions. |
| Versius is simply another version of da Vinci. | It is a separate robotic platform developed by CMR Surgical with a modular bedside-unit design. |
| Because Versius is newer, it must give better results. | Newer technology does not automatically improve cancer or functional outcomes. |
| Its modular design proves better cancer control. | Modularity mainly affects system configuration and workflow; it has not been shown to provide superior cancer control. |
| Early good results prove Versius is equivalent to da Vinci. | Current studies are encouraging but generally involve small numbers and relatively short follow-up. |
| Versius guarantees better continence or erectile recovery. | Current evidence does not establish this. Patient factors, nerve-sparing and surgical technique remain important. |
Key Takeaways
- Versius is a surgeon-controlled modular robotic platform developed by Cambridge-based CMR Surgical.
- It received its European CE mark in 2019 and was first used for UK prostate removal at Guy’s Hospital in December 2021.
- Its separate bedside units and open console distinguish its design from da Vinci systems.
- Published prostatectomy evidence is growing, including prospective comparative research.
- Current studies do not establish that Versius produces better cancer, continence or erectile-function outcomes than established robotic platforms.
- Surgeon and theatre-team experience with the specific system remains important.
Frequently Asked Questions
1. What Is the Versius Robotic Surgical System?
Versius is a surgeon-controlled robotic system developed by CMR Surgical in Cambridge, UK. It uses separate robotic units, a 3D camera and wristed instruments that your surgeon controls from a dedicated console.
2. How Is Versius Different From Da Vinci?
Unlike da Vinci, Versius uses separate mobile units for its camera and surgical instruments rather than one integrated patient-side structure. Your surgeon can position these units independently around you, giving the surgical team greater flexibility in the operating theatre.
3. How Does Your Surgeon Control Versius?
Your surgeon controls Versius from a dedicated console while viewing a magnified 3D image of your anatomy. The system translates your surgeon’s hand movements into precise movements of the instruments, while your bedside team continues to assist you.
4. How Is Versius Used for Radical Prostatectomy?
Your surgeon can use Versius to remove your prostate and usually the seminal vesicles. Depending on your cancer, nearby lymph nodes may also be removed and your surgeon may try to preserve the nerves involved in erections before reconnecting your bladder to your urethra.
5. When Was Versius First Used for Prostate Surgery in the UK?
The first UK prostate removal using Versius took place at Guy’s Hospital in December 2021. Since then, more clinical experience and research have become available, although Versius still has less long-term prostate surgery evidence than da Vinci.
6. What Does Early Research Say About Versius Prostatectomy?
Early studies have demonstrated the feasibility of performing prostatectomy with Versius and reported encouraging short-term outcomes. However, the research has generally involved relatively small numbers of patients, so more evidence is needed to understand long-term cancer control, urinary function and sexual recovery.
7. What Did the 2025 Meta-Analysis Find About Versius Prostatectomy?
A 2025 review combined four studies involving 145 patients and assessed outcomes including operating time, blood loss, complications, surgical margins and continence recovery. The findings provide early information, but the studies were small and varied, so they cannot predict your individual recovery.
8. Is Urinary Continence Better With Versius?
Early studies report improving continence rates during the first few months after Versius prostatectomy. However, your age, pre-surgery urinary function, anatomy, surgical technique and how carefully surrounding structures are preserved can all affect your recovery.
9. Does Versius Improve Erectile-Function Recovery?
There is currently not enough evidence to show that Versius gives you better erectile recovery than other robotic systems. Your erections before surgery, age, cancer location, nerve-sparing and your surgeon’s experience can all affect your outcome.
10. What Are the Advantages and Limitations of Versius?
Versius may give your surgical team flexibility through its separate robotic units, open console, 3D vision and wristed instruments. However, it is newer than da Vinci and has less long-term prostate surgery evidence, so you should consider your surgeon’s experience and the available research when discussing whether it is suitable for you.
Final Thoughts: What Should You Know About Versius Robotic Prostate Surgery?
Versius is an emerging robotic system that offers your surgeon 3D vision, wristed instruments and flexible positioning during prostate surgery. For you, the robot is only one factor to consider, as your surgeon’s experience, surgical approach, individual cancer and the developing evidence for Versius are also important.
If you are considering robotic prostate surgery in London and would like specialist advice, you can contact our team to discuss your treatment options and arrange a consultation tailored to your individual needs.
References:
- Chen, S.-Y., Ma, Y., Yang, J.-W., Liu, H., Wang, L. and Li, X.-R. (2025) ‘Safety and functional outcomes of Versius surgical platform in prostate cancer radical prostatectomy: a single arm meta-analysis’, Journal of Robotic Surgery, 19(1), article 284. Available at:
https://pubmed.ncbi.nlm.nih.gov/40504465/ - Meneghetti, I., Dibitetto, F., Mariotti, A., Morganti, R., Collins, J.W., Pacetti, P., Corsini, A. et al. (2026) ‘Preliminary Multicenter Experience With the Versius Robotic Surgical System for Radical Prostatectomy: Oncological Outcomes With a Minimum 18-Month of Follow-Up’, The International Journal of Medical Robotics and Computer Assisted Surgery, 22(2), e70144. Available at:
https://pubmed.ncbi.nlm.nih.gov/41755766/ - Antonelli, A. et al. (2025) ‘First prospective comparison between Versius and DaVinci Xi for robotic radical prostatectomy: focus on operative room setup, surgical timing, troubleshooting, and surgeon satisfaction (COMPAR-P Trial)’, Minerva Urology and Nephrology, 77(5), pp. 655–663. Available at: https://pubmed.ncbi.nlm.nih.gov/41128034/
- Antonelli, A. et al. (2026) ‘Six-month outcomes of a three-arm prospective study comparing Da Vinci vs. Hugo RAS vs. Versius robotic radical prostatectomy: the COMPAR-P trial’, Journal of Robotic Surgery, 20(1), article 361. Available at: https://pubmed.ncbi.nlm.nih.gov/41851411/
- National Institute for Health and Care Excellence (NICE) (2025) ‘Robot-assisted surgery for soft tissue procedures: early value assessment’, HealthTech guidance HTG742. Available at: https://www.nice.org.uk/guidance/htg742
- Guy’s and St Thomas’ NHS Foundation Trust (2021) ‘Next-generation robot lands at Guy’s and St Thomas’’. Available at: https://www.guysandstthomas.nhs.uk/news/next-generation-robot-lands-guys-and-st-thomas
- Hughes, T., Rai, B., Madaan, S., Chedgy, E. and Somani, B. (2023) ‘The Availability, Cost, Limitations, Learning Curve and Future of Robotic Systems in Urology and Prostate Cancer Surgery’, Journal of Clinical Medicine, 12(6), article 2268. Available at:
https://www.mdpi.com/2077-0383/12/6/2268